Neuroimmuno Flashcards

1
Q

MOA of natalizumab

A

monoclonal Ab against alpha-4-integrin cellular adhesion molecule

binds lymphocytes and stops them from adhering to blood vessels in brain and gut

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

risk of developing PML on natalizumab

A

1 in 1000

higher with prior immunosuppression, using other immunosuppressants, and after 2 years of continuous use

+ JC virus antibodies even higher risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what to do if anaphylaxis to natalizumab

A

common - 1 in 50 patients by 4th dose will get

STOP infusion, treat anaphylaxis, DO NOT RESTART natalizumab. It’s over.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

symptoms of progressive multifocal leukoencephalopathy. MRI? what to do if you suspect PML?

A

aphasia, visual field deficits, headache, hemiparesis, cognitive dysfunction over weeks

MRI shows focal subcortical lesions in multiple brain areas, may look like MS lesions

if PML suspected, stop natalizumab, check JC virus PCR, and start PLEX to clear remaining natalizumab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

transverse myelitis - presentations and causes

A

subacute myelopathy, seems to be immunologic
sensory level, weakness, back pain, bowel/bladder dysfunction

may occur after viral illness, Mycoplasma infection, or vaccination, often not preceded by illness

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

FDA approved to improve walking in patients with MS

A

dalfampridine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

FDA approved to improve walking in patients with MS

A

dalfampridine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Oppenheim syndrome in MS

A

MS patient relapses, can move their hand but think it’s useless.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Pulfrich’s sign in MS

A

can’t follow moving objects visually, lateral motion looks like it has a depth component

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

alemtuzumab MOA and side effects

A

anti CD-52 - cellular mediated lysis of B and T cells
alemtwozumab
risks of hyperthyroidism and ITP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

if MS patient on this med wants to become pregnant, need a cholestyramine washout prior to conception because it’s teratogenic

A

teriflunomide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

MS drug that is safe in pregnancy

A

glatimer acetate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

MS drug that has risk of bradycardia and need 1st dose monitoring

A

fingolimod

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Lhermitte’s sign associated with lesion where

A

cervical cord demyelination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

middle aged man develops focal seizures involving right face and arm lasting seconds - synchronous jerking of face and arm. remains conscious during these but they dont respond to AEDs. then he becomes confused and has memory loss. diagnosis?

A

LGI1 limbic encephalitis - faciobrachiodystonic seizures

doesn’t respond to AEDs but responds to immunotherapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

which MS med causes flushing and GI upset

A

dimethyl fumarate

16
Q

which MS med is associated with severe/fatal VZV infection

A

fingolimod

17
Q

fingolimod MOA

A

binds sphingosine-1-P receptor on lymphocytes

causes internalization - cells can’t egress from lymph nodes (can’t escape lymph nodes - locked up)

18
Q

dalfampridine side effect

A

incr risk of seizure esp with renal failure
makes MS patients walk fast tho –

19
Q

MS Med with risk of lipoatrophy

A

Glatimer acetate

20
Q

Med approved for primary progressive MS

A

Ocrelizumab anti- CD 20

21
Q

MS Med with risk of neutralizing antibodies

A

Interferons

22
Q

Multiple demyelinating lesions with hemorrhage

A

Hurst disease - acute hemorrhagic leukoencephalitis

23
Q

Mitoxantrone

A

Approved for secondary progressive MS
Can cause dose related heart toxicity
Also alopecia menstrual irregularities

24
Q

Onion bulbs on brain biopsy

A

Balo’s concentric MS
Alternating bands of demyelination and preserved myelination

25
Q

Krabbe gene mutation

A

GALC gene —> galactocerebrosidase deficiency

26
Q

Diffuse demyelination with U fiber involvement, accumulation of N acetylasparate

A

Canavan disease

27
Q

Tigroid demyelination

A

Tends to refer to Pelizaeus Merzbacher on exam questions
Nystagmus, ataxia, tremor

28
Q

PLP1 gene mutation

A

Pelizaeus Merzbacher disease
X linked
Tigroid